The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAbrdn Di&g Regulatory News (ADIG)

Share Price Information for Abrdn Di&g (ADIG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 77.20
Bid: 77.20
Ask: 78.60
Change: 0.40 (0.52%)
Spread: 1.40 (1.813%)
Open: 76.60
High: 78.60
Low: 76.60
Prev. Close: 76.80
ADIG Live PriceLast checked at -
Aberdeen Diversified Income & Growth is an Investment Trust

To target a total portfolio return of LIBOR (London Interbank Offered Rate) plus 5.5% p.a. (net of fees) over rolling five-year periods through investments from the widest range of asset classes.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Edison reviews Aberdeen Diversified Income Trust

17 Mar 2020 17:15

RNS Number : 5277G
Aberdeen Diversified I&G Trust PLC
17 March 2020
 

 

London, UK, 17 March 2020

Edison issues review on Aberdeen Diversified Income and Growth Trust (ADIG)

Aberdeen Diversified Income and Growth Trust (ADIG) aims to generate attractive long-term income and capital returns from its diversified multi-asset portfolio. In line with the March 2017 strategy change, the process of recycling capital from listed to longer-term, unlisted holdings is continuing. These should represent c 43% of NAV (vs 26% at end-September 2019) on full deployment of existing commitments. ADIG's underperformance since the strategy change reflects, among other things, ongoing portfolio repositioning, issues with its insurance-linked and litigation finance holdings and the value bias of its listed equity exposure. Since end-May 2019, the discount to NAV has been above the targeted 5%. That said, ADIG outperformed its benchmark over the last 12 months and it continues to offer an attractive prospective dividend yield of c 5.6%.

 

Since the strategy change in March 2017, ADIG's NAV TR performance has lagged its benchmark (Libor + 5.5%), which has resulted in a NAV discount in excess of 5% in recent months. Over the 12 months to January 2020, the NAV TR of 7.5% was ahead of the benchmark, aided by the solid performance of emerging market bonds and asset-backed securities. The last 12 months (LTM) dividend yield of 5.5% is ahead of most of its peers.

Click here to view the full report.

 

Subscribe to Edison's content to receive reports by email.

All reports published by Edison are free-to-access and available on the website.

 

About Edison: Edison is an investment research and advisory company, with offices in North America, Europe, the Middle East and AsiaPac. The heart of Edison is our world-renowned equity research platform and deep multi-sector expertise. At Edison Investment Research, our research is widely read by international investors, advisers and stakeholders. Edison Advisors leverages our core research platform to provide differentiated services including investor relations and strategic consulting.

Edison is authorised and regulated by the Financial Conduct Authority.

Edison is not an adviser or broker-dealer and does not provide investment advice. Edison's reports are not solicitations to buy or sell any securities.

For more information please contact Edison:

Milosz Papst, +44 (0) 20 3077 5700

investmenttrustss@edisongroup.com

 

Learn more at www.edisongroup.com and connect with Edison on:

LinkedIn https://www.linkedin.com/company/edison-group- 

Twitter www.twitter.com/Edison_Inv_Res 

YouTube www.youtube.com/edisonitv 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
NRAGPUGGWUPUGMM
Date   Source Headline
10th Mar 20232:33 pmRNSPortfolio disclosure
10th Mar 202312:36 pmRNSNet Asset Value(s)
9th Mar 20235:10 pmRNSTransaction in Own Shares
9th Mar 202312:31 pmRNSNet Asset Value(s)
8th Mar 20235:04 pmRNSTransaction in Own Shares
8th Mar 202311:40 amRNSNet Asset Value(s)
7th Mar 202312:15 pmRNSNet Asset Value(s)
6th Mar 20236:18 pmRNSMonth End Net Asset Value(s)
6th Mar 20235:10 pmRNSTransaction in Own Shares
6th Mar 20233:24 pmRNSGearing disclosure
6th Mar 202312:50 pmRNSNet Asset Value(s)
3rd Mar 20235:12 pmRNSTransaction in Own Shares
3rd Mar 202312:32 pmRNSNet Asset Value(s)
2nd Mar 20235:10 pmRNSTransaction in Own Shares
2nd Mar 20232:53 pmRNSNet Asset Value(s)
2nd Mar 20237:00 amRNSFirst Interim Dividend
1st Mar 20239:45 amRNSTotal Voting Rights
28th Feb 20234:32 pmRNSResult of AGM
28th Feb 202312:33 pmRNSNet Asset Value(s)
27th Feb 20235:01 pmRNSTransaction in Own Shares
27th Feb 20232:04 pmRNSGearing disclosure
27th Feb 202312:35 pmRNSNet Asset Value(s)
24th Feb 20235:19 pmRNSTransaction in Own Shares
24th Feb 20231:32 pmRNSNet Asset Value(s)
23rd Feb 20235:23 pmRNSTransaction in Own Shares
23rd Feb 202311:41 amRNSNet Asset Value(s)
22nd Feb 202311:37 amRNSNet Asset Value(s)
21st Feb 202310:58 amRNSNet Asset Value(s)
20th Feb 20235:25 pmRNSTransaction in Own Shares
20th Feb 20231:35 pmRNSGearing disclosure
20th Feb 202312:37 pmRNSNet Asset Value(s)
17th Feb 20235:03 pmRNSTransaction in Own Shares
17th Feb 202312:34 pmRNSNet Asset Value(s)
16th Feb 20235:03 pmRNSTransaction in Own Shares
16th Feb 202312:07 pmRNSNet Asset Value(s)
15th Feb 20235:05 pmRNSTransaction in Own Shares
15th Feb 202311:31 amRNSNet Asset Value(s)
14th Feb 20235:19 pmRNSTransaction in Own Shares
14th Feb 20234:06 pmRNSPortfolio disclosure
14th Feb 202312:28 pmRNSNet Asset Value(s)
13th Feb 20233:48 pmRNSGearing disclosure
13th Feb 202312:29 pmRNSNet Asset Value(s)
10th Feb 20234:55 pmRNSTransaction in Own Shares
10th Feb 202312:41 pmRNSNet Asset Value(s)
9th Feb 20235:22 pmRNSTransaction in Own Shares
9th Feb 20231:05 pmRNSNet Asset Value(s)
8th Feb 20235:11 pmRNSTransaction in Own Shares
8th Feb 20231:24 pmRNSNet Asset Value(s)
7th Feb 20235:07 pmRNSTransaction in Own Shares
7th Feb 20231:28 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.